Pursuing the Dream of Cure: Advancing Curative Therapy for Esophagogastric Cancer

Dienstag, 26.01.2027 - 13:00 - 16:00 Uhr
Stream auf Englisch

Pursuing the Dream of Cure: Advancing Curative Therapy for Esophagogastric Cancer

Advances in multimodal treatment are reshaping the therapeutic landscape of esophagogastric cancer and opening new perspectives for curative-intent strategies. Yet important questions remain: Which patients may benefit from organ preservation? How can perioperative treatment be optimized? And can selected patients with oligometastatic disease achieve long-term disease control or even cure?

Chaired by Prof. Dr. Salah-Eddin Al-Batran and moderated by Prof. Dr. Thorsten Götze and Yan Sun, MD, PhD, this international summit brings together leading experts from Europe, Asia, the Americas, and the Middle East to exchange perspectives on current and emerging curative treatment strategies.

Beyond reviewing current standards of care, the summit will look ahead to explore how curative treatment may evolve in the coming years. Through critical evaluation of emerging evidence, innovative therapeutic approaches, and unresolved clinical questions, the international faculty will identify opportunities to advance curative treatment and improve patient outcomes worldwide.

Three dedicated sessions will address key challenges in the management of esophagogastric cancer: organ preservation in early-stage disease, evolving perioperative strategies for locally advanced resectable tumors, and the potential of curative-intent treatment in oligometastatic disease.

A particular focus will be placed on regional differences in treatment approaches, access to innovative therapies, regulatory frameworks, and barriers to implementation in clinical practice. Interactive panel discussions will actively encourage perspectives from different regions, highlighting shared experiences, areas of consensus, ongoing controversies, and opportunities for international collaboration.

The shared ambition: to foster global scientific dialogue, translate emerging evidence into clinical progress, and help shape the future of curative therapy for esophagogastric cancer — bringing the prospect of cure closer to more patients worldwide.

Salah-Eddin Al-Batran Prof. Humaid Al-Shamsi, MD, MRCP, FRCP, FACP Maria Ignez Braghiroli Christiane Bruns Thorsten Oliver Götze Vikas Ostwal, MD, DM Kohei Shitara, MD Yan Sun, MD, PhD Dr. Yelena Y. Janjigian, MD Prof. Kun Yang, MD

Pursuing the Dream of Cure will take place at the following times across different time zones:

EST (UTC−5) New York 07:00–10:00

BRT (UTC-3) Sao Paulo 09:00–12:00

CET (UTC+1) Berlin 13:00–16:00

GST (UCT+4) Abu Dhabi 16:00–19:00

IST (UTC+5:30) Mumbai 17:30–20:30

CST (UTC+8) Chengdu 20:00–23:00

JST (UTC+9) Chiba 21:00–00:00


Chair of the Summit: Prof. Dr. Salah-Eddin Al-Batran
Moderators: Prof. Dr. Thorsten Götze and Yan Sun, MD, PhD

1:00 p.m. (CET) Opening and Welcome
1:10 p.m. (CET) Organizational Notes


Session 1: 
Organ Preservation in Early-Stage Disease – Has the Time Come?

1:15 p.m. (CET) Keynote: Organ Preservation in Gastroesophageal Adenocarcinoma: Are We Ready?
Prof. Dr. Salah-Eddin Al-Batran

1:25 p.m. (CET) Panel Discussion: How Do You Do This in Your Country?
Entire Faculty


Session 2:
Locally Advanced Resectable Disease – Optimizing Curative Treatment

1:55 p.m. (CET) Keynote: The Evolving Standard of Perioperative Treatment: From FLOT4 and ESOPEC to MATTERHORN

  • The Western Perstpective
    Dr. Yelena Y. Janjigian, MD
  • The Asian Perspective
    Kohei Shitara, MD

2:11 p.m. (CET) Panel Discussion: How Do You Do This in Your Country?
Entire Faculty



2:55 p.m. (CET) Break 
Sponsor Session



Session 3:
Oligometastatic Disease – Can Selected Patients Be Cured?

3:15 p.m. (CET) Keynote: From FLOT3 to FLOT5 and Beyond: The Evidence for Curative-Intent Treatment in Oligometastatic Disease
Prof. Humaid Al-Shamsi, MD, MRCP, FRCP, FACP

3:25 p.m. (CET) Panel Discussion: How Do You Do This in Your Country?
Entire Faculty 


3:55 p.m. (CET) Summary of key insights and takeaways - Outlook emerging therapies and future collaborations
Entire Faculty


4:00 p.m. (CET) End of the Summit

 
Prof. Dr. Salah-Eddin Al-Batran
Krankenhaus Nordwest
 
Prof. Humaid Al-Shamsi, MD, MRCP, FRCP, FACP
Burjeel Cancer Institute
 
Dr. Maria Ignez Braghiroli
São Paulo State Cancer Institute
 
Prof. Dr. Christiane Bruns
Universitätsklinikum Köln
 
Prof. Dr. Thorsten Oliver Götze
Krankenhaus Nordwest
 
Vikas Ostwal, MD, DM
Tata Memorial Centre
 
Kohei Shitara, MD
National Cancer Center Hospital East
 
Yan Sun, MD, PhD
Maastricht University & World Young Scientist Summit (WYSS), Brussels / Shanghai, China
 
Dr. Yelena Y. Janjigian, MD
Memorial Sloan Kettering Cancer Center
 
Prof. Kun Yang, MD
West China Hospital
Logo AstraZeneca
AstraZeneca
Logo IKF - Frankfurt Institute of Clinical Cancer Research (IKF)
IKF - Frankfurt Institute of Clinical Cancer Research (IKF)